{{Drugbox
| IUPAC_name = D-phenylalanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-tryptophanamide (2->7)-disulfide
| synonyms = H-D-Phe-Cys(1)-Tyr-D-Trp-Lys-Val-Cys(1)-Trp-NH2<br/>Octastatin
| image =  Vapreotide.svg
| width =
| alt =  
| image2 =  
| width2 =  
| drug_name = 
| caption =  
<!--Clinical data-->
| tradename = Sanvar
| licence_EU = <!-- EMA requires brand name -->
| licence_US = <!-- FDA may use generic name -->
| DailyMedID = <!-- preference to licence_US -->
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, CD Lic, CD POM, CD No Reg POM, CD (Benz) POM, CD (Anab) POM or CD Inv POM -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status =  
| dependency_liability =  
| routes_of_administration =  
<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life = 30 minutes
| excretion =  
<!--Identifiers-->
| CAS_number = 103222-11-3
| CAS_supplemental =  
| ATCvet =  
| ATC_prefix = H01
| ATC_suffix = CB04
| ATC_supplemental =  
| UNII = 2PK59M9GFF
| PubChem = 23725064
| PubChemSubstance = 46506923
| IUPHAR_ligand =  
| DrugBank = DB04894
| ChemSpiderID = 64425
| KEGG = D06281
<!--Chemical data-->
| C=57 | H=70 | N=12 | O=9 | S=2
| molecular_weight = 1131.37 g/mol
| SMILES = CC(C)[C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCCCN)Cc2c[nH]c3c2cccc3)Cc4ccc(cc4)O)NC(=O)[C@@H](Cc5ccccc5)N)C(=O)N[C@@H](Cc6c[nH]c7c6cccc7)C(=O)N
| StdInChI = 1S/C57H70N12O9S2/c1-32(2)49-57(78)68-48(55(76)64-44(50(60)71)26-35-28-61-41-16-8-6-14-38(35)41)31-80-79-30-47(67-51(72)40(59)24-33-12-4-3-5-13-33)56(77)65-45(25-34-19-21-37(70)22-20-34)53(74)66-46(27-36-29-62-42-17-9-7-15-39(36)42)54(75)63-43(52(73)69-49)18-10-11-23-58/h3-9,12-17,19-22,28-29,32,40,43-49,61-62,70H,10-11,18,23-27,30-31,58-59H2,1-2H3,(H2,60,71)(H,63,75)(H,64,76)(H,65,77)(H,66,74)(H,67,72)(H,68,78)(H,69,73)/t40-,43+,44+,45+,46-,47+,48+,49+/m1/s1
| StdInChIKey = SWXOGPJRIDTIRL-DOUNNPEJSA-N
| density = 1.4 
| melting_point =  
| melting_high =  
| melting_notes =  
| boiling_point = 1540.9 
| boiling_notes =  
| solubility =  
| specific_rotation =  
| sec_combustion =  
}}

'''Vapreotide''' ('''Sanvar''') is a synthetic [[somatostatin]] analog. It is used in the treatment of [[Cirrhosis|esophageal variceal bleeding]] in patients with cirrhotic [[liver disease]] and [[AIDS]]-related [[diarrhea]].<ref name="DrugBank">{{DrugBank|DB04894}}</ref>

It is an 8 residue peptide with sequence H-D-Phe-Cys(1)-Tyr-D-Trp-Lys-Val-Cys(1)-Trp-NH2.

==References==
{{Reflist|2}}


{{GH/IGF-1 axis signaling modulators}}

[[Category:Antineoplastic drugs]]
[[Category:Lactams]]
[[Category:Peptides]]
[[Category:Hormonal agents]]


{{systemic-hormonal-drug-stub}}